Regencell Bioscience (RGC) has had the highest return this year by a US stock with a market cap of $10B+, returning 139.9%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Regencell Bioscience (RGC) | 2026 | 139.93% |
Sandisk (SNDK) | 2026 | 44.69% |
Oklo (OKLO) | 2026 | 31.91% |
Amkor Technology (AMKR) | 2026 | 28.43% |
AeroVironment (AVAV) | 2026 | 28.19% |
Revolution Medicines (RVMD) | 2026 | 27.92% |
Karman (KRMN) | 2026 | 23.56% |
Fortress Transp & Infra Inv (FTAI) | 2026 | 21.51% |
QXO (QXO) | 2026 | 21.45% |
MP Materials (MP) | 2026 | 21.41% |
Moderna (MRNA) | 2026 | 20.32% |
Kratos Defense & Security Solutions (KTOS) | 2026 | 19.45% |
Bloom Energy (BE) | 2026 | 19.24% |
Rocket Lab USA (RKLB) | 2026 | 19.04% |
Alcoa (AA) | 2026 | 15.93% |
Tempus AI, Inc Class A Common Stock (TEM) | 2026 | 15.88% |
Joby Aviation (JOBY) | 2026 | 15.61% |
Ast Spacemobile (ASTS) | 2026 | 15.32% |
Micron Technology (MU) | 2026 | 15.05% |
Symbotic (SYM) | 2026 | 14.47% |
Illumina (ILMN) | 2026 | 14.32% |
Globalfoundries (GFS) | 2026 | 14.24% |
Lam Research (LRCX) | 2026 | 14.19% |
United Microelectronics (UMC) | 2026 | 13.76% |
Entegris (ENTG) | 2026 | 13.57% |
